H.R. 4101

119th CongressIn committee

Cancer Drug Parity Act of 2025

Cancer Drug Parity Act of 2025

Sponsored by Glenn Grothman (Republican-WI-6)

Healthcare Costs & Access Healthcare & Public Health Pharmaceutical Policy

Cosponsors

27

Actions

3

Roll calls

0

Amendments

0

Related bills

0

Actions

Jun 24, 2025 · Library of Congress

Introduced in House

Jun 24, 2025 · Library of Congress

Introduced in House

Jun 24, 2025 · House floor actions

Referred to the House Committee on Education and Workforce.

Latest activity

Activity

July 2026

Lobbying reported · Cavarocchi Ruscio Dennis Associates, L.l.c. · Jul 17

Cavarocchi Ruscio Dennis Associates, L.l.c. reported 2nd Quarter (Apr 1 - June 30) lobbying for Hematology Oncology Pharmacy Association — $50,000

BillsH.R. 4101 H.R. 5509 S. 2903

Lobbying reported · Association for Clinical Oncology (ASCO) · Jul 16

Association for Clinical Oncology (ASCO) reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Clinical Oncology (ASCO) — $480,000

You’re all caught up.